drugset / Trial / NCT03471559
Cannabidiol - an in Vivo Innovative Drug Delivery Study
RandomizedCrossoverOpen-labelBasic science
Summary
Basic characterization of the drug delivery system for cannabidiol. A comparative bioavailability study.
Timeline
- Start
- 2018-12-10
- Primary completion
- 2019-06-30
- Completion
- 2019-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 200 mg | Intranasal |
Indications
No indication recorded.